搜索





搜索





Edgewise Therapeutics Inc

EWTX

添加自选

45.320USD

-1.620-3.45%

收盘 09-18 16:00（美东）

4.89B总市值

亏损市盈率 TTM

盘后交易 16:13 (美东)45.220USD-0.150-0.33%

Edgewise Therapeutics Inc

45.320

-1.620-3.45%

财务摘要利润表资产负债表现金流量表财报公司估值风险评估

概览

新闻分析

财务

股票评分

技术分析

预测

持股情况

股息

公司资料

财务摘要利润表资产负债表现金流量表财报公司估值风险评估

EWTX 利润表

您可以在这里找到Edgewise Therapeutics Inc的年度或季度收入报告，以深入了解Edgewise Therapeutics Inc的运营、管理效率和表现。

单季报

单季报+年报

单季报

年报

YOY

隐藏空白行

FY2026Q2

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

营业费用

45.37%61.94M

17.75%54.12M

22.92%55.98M

15.89%46.86M

11.82%42.61M

32.24%45.96M

34.49%45.54M

37.28%40.43M

50.39%38.11M

35.20%34.75M

53.37%33.86M

61.27%29.45M

53.65%25.34M

73.37%25.70M

72.20%22.08M

39.66%18.26M

57.66%16.49M

116.22%14.83M

102.11%12.82M

258.93%13.08M

164.34%10.46M

111.11%6.86M

--6.34M

--3.64M

--3.96M

--3.25M

研发费用

41.69%47.55M

16.04%42.65M

19.86%43.59M

16.32%37.48M

9.38%33.56M

32.73%36.76M

31.38%36.37M

35.47%32.22M

56.86%30.68M

39.33%27.69M

66.65%27.68M

71.20%23.79M

57.71%19.56M

78.68%19.88M

82.79%16.61M

40.63%13.89M

57.77%12.40M

107.54%11.12M

76.84%9.09M

205.13%9.88M

116.02%7.86M

80.65%5.36M

--5.14M

--3.24M

--3.64M

--2.97M

折旧摊销及损耗

3.44%541.00K

-3.07%537.00K

-16.53%525.00K

-2.97%523.00K

8.96%523.00K

17.12%554.00K

30.23%629.00K

20.04%539.00K

13.21%480.00K

142.56%473.00K

448.86%483.00K

349.00%449.00K

337.11%424.00K

134.94%195.00K

12.82%88.00K

56.25%100.00K

90.20%97.00K

5.06%83.00K

56.00%78.00K

28.00%64.00K

13.33%51.00K

97.50%79.00K

--50.00K

--45.00K

--40.00K

营业利润

-45.37%-61.94M

-17.75%-54.12M

-22.92%-55.98M

-15.89%-46.86M

-11.82%-42.61M

-32.24%-45.96M

-34.49%-45.54M

-37.28%-40.43M

-50.39%-38.11M

-35.20%-34.75M

-53.37%-33.86M

-61.27%-29.45M

-53.65%-25.34M

-73.37%-25.70M

-72.20%-22.08M

-39.66%-18.26M

-57.66%-16.49M

-116.22%-14.83M

-102.11%-12.82M

-258.93%-13.08M

-164.34%-10.46M

-111.11%-6.86M

---6.34M

---3.64M

---3.96M

---3.25M

净非营业利息收入（费用）

利息收入

-28.93%4.62M

-1.14%5.10M

-1.96%5.76M

-1.76%6.19M

-1.74%6.50M

-17.13%5.16M

58.05%5.88M

68.57%6.30M

70.80%6.61M

117.31%6.23M

39.60%3.72M

389.40%3.74M

812.74%3.87M

1626.51%2.87M

2014.29%2.66M

501.57%764.00K

296.26%424.00K

295.24%166.00K

6200.00%126.00K

12600.00%127.00K

3466.67%107.00K

-33.33%42.00K

--2.00K

--1.00K

--3.00K

--63.00K

税前利润

-58.73%-57.33M

-20.14%-49.01M

-26.61%-50.22M

-19.15%-40.67M

-14.66%-36.12M

-43.03%-40.80M

-31.58%-39.66M

-32.73%-34.13M

-46.71%-31.50M

-24.90%-28.52M

-55.26%-30.14M

-46.95%-25.71M

-33.62%-21.47M

-55.78%-22.84M

-52.92%-19.41M

-35.13%-17.50M

-55.19%-16.07M

-115.11%-14.66M

-100.19%-12.70M

-255.55%-12.95M

-161.84%-10.35M

-113.97%-6.81M

---6.34M

---3.64M

---3.95M

---3.19M

所得税

----

--0.00

----

除税后利润

-58.73%-57.33M

-20.14%-49.01M

-26.61%-50.22M

-19.15%-40.67M

-14.66%-36.12M

-43.03%-40.80M

-31.58%-39.66M

-32.73%-34.13M

-46.71%-31.50M

-24.90%-28.52M

-55.26%-30.14M

-46.95%-25.71M

-33.62%-21.47M

-55.78%-22.84M

-52.92%-19.41M

-35.13%-17.50M

-55.19%-16.07M

-115.11%-14.66M

-100.19%-12.70M

-255.55%-12.95M

-161.84%-10.35M

-113.97%-6.81M

---6.34M

---3.64M

---3.95M

---3.19M

持续经营利润

-58.73%-57.33M

-20.14%-49.01M

-26.61%-50.22M

-19.15%-40.67M

-14.66%-36.12M

-43.03%-40.80M

-31.58%-39.66M

-32.73%-34.13M

-46.71%-31.50M

-24.90%-28.52M

-55.26%-30.14M

-46.95%-25.71M

-33.62%-21.47M

-55.78%-22.84M

-52.92%-19.41M

-35.13%-17.50M

-55.19%-16.07M

-115.11%-14.66M

-100.19%-12.70M

-255.55%-12.95M

-161.84%-10.35M

-113.97%-6.81M

---6.34M

---3.64M

---3.95M

---3.19M

归属于母公司的净利润

-58.73%-57.33M

-20.14%-49.01M

-26.61%-50.22M

-19.15%-40.67M

-14.66%-36.12M

-43.03%-40.80M

-31.58%-39.66M

-32.73%-34.13M

-46.71%-31.50M

-24.90%-28.52M

-55.26%-30.14M

-46.95%-25.71M

-33.62%-21.47M

-55.78%-22.84M

-52.92%-19.41M

-35.13%-17.50M

-55.19%-16.07M

-115.11%-14.66M

-100.19%-12.70M

-255.55%-12.95M

-161.84%-10.35M

-113.97%-6.81M

---6.34M

---3.64M

---3.95M

---3.19M

归属于普通股东的净利润

-58.73%-57.33M

-20.14%-49.01M

-26.61%-50.22M

-19.15%-40.67M

-14.66%-36.12M

-43.03%-40.80M

-31.58%-39.66M

-32.73%-34.13M

-46.71%-31.50M

-24.90%-28.52M

-55.26%-30.14M

-46.95%-25.71M

-33.62%-21.47M

-55.78%-22.84M

-52.92%-19.41M

-35.13%-17.50M

-55.19%-16.07M

-115.11%-14.66M

-100.19%-12.70M

-255.55%-12.95M

-161.84%-10.35M

-113.97%-6.81M

---6.34M

---3.64M

---3.95M

---3.19M

基本每股收益

-54.71%-0.53

-6.69%-0.46

-13.11%-0.47

-5.96%-0.39

-2.18%-0.34

-31.66%-0.43

10.02%-0.42

10.21%-0.36

0.57%-0.34

9.76%-0.33

-51.79%-0.47

-20.05%-0.41

-4.62%-0.34

-21.99%-0.36

-19.50%-0.31

-28.41%-0.34

-54.05%-0.32

-106.53%-0.30

-92.38%-0.26

-243.27%-0.26

-152.86%-0.21

-113.96%-0.14

---0.13

---0.08

---0.07

稀释每股收益

-54.71%-0.53

-6.69%-0.46

-13.11%-0.47

-5.96%-0.39

-2.18%-0.34

-31.66%-0.43

10.02%-0.42

10.21%-0.36

0.57%-0.34

9.76%-0.33

-51.79%-0.47

-20.05%-0.41

-4.62%-0.34

-21.99%-0.36

-19.50%-0.31

-28.41%-0.34

-54.05%-0.32

-106.53%-0.30

-92.38%-0.26

-243.27%-0.26

-152.86%-0.21

-113.96%-0.14

---0.13

---0.08

---0.07

每股派息

--0.00

货币单位

--USD

审计意见

----

常见问题

如何在 TradingKey 上查看 Edgewise Therapeutics Inc 的利润表？



先看总营收，再依次查看营收成本、毛利润、营业费用、营业利润、税前利润、净利润和每股收益（EPS）。营收反映公司的业务规模，而各项利润和利润率则体现公司能否有效地将营收转化为盈利。

季度利润表和年度利润表有什么区别？



季度利润表反映公司在一个为期三个月的财务季度内的经营表现，年度利润表则汇总整个财年的业绩。季度数据适合用于观察近期发展势头和季节性变化，年度数据则更适合评估长期增长、盈利能力和业务周期。

利润表页面中的同比是什么意思？



同比是指将某项财务指标与上年同期进行比较，例如将本季度营收与去年同一季度的营收进行对比。同比数据有助于投资者观察增长趋势，同时减少正常季节性变化对分析的影响。

分析 EWTX 股票时，哪些利润表指标最重要？



重要的指标包括营收增长、毛利润、毛利率、营业利润、营业利润率、净利润、每股收益、研发费用、销售及管理费用以及所得税费用。投资者通常会综合分析这些指标，以判断公司是否正在增长、有效控制成本并提升盈利能力。

Edgewise Therapeutics Inc 全年的净利润是多少？



Edgewise Therapeutics Inc 2025 财年净利润为 -167.79M。

Edgewise Therapeutics Inc 上一季度的净利润是多少？



Edgewise Therapeutics Inc 最近一个季度的净利润为 -57.33M。

Edgewise Therapeutics Inc 年度营业利润是多少？



Edgewise Therapeutics Inc 2025 财年的营业利润为 -191.41M。

每股收益与利润表有什么关系？



每股收益（EPS）通常以净利润除以流通在外的股份数量计算，用于衡量公司平均每股创造的利润。分析 EPS 时，还应结合股本变化、利润率、现金流和估值指标进行综合判断。